HSA Approval

OPTIZOLINE EYE DROPS 0.05%

Approval Number

SIN06918P

Drug Name

Product Name

OPTIZOLINE EYE DROPS 0.05%

Approval Date

March 23, 1992

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

SOLUTION

Route of Administration

OPHTHALMIC

Medical Information

ATC Code

S01GA02

ATC Item Name

tetryzoline

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

Ingredient Name

TETRAHYDROZOLINE HCl

Strength

0.05%

Drug MonographTetryzoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

OPTIZOLINE EYE DROPS 0.05% - HSA Approval | MedPath

AI-Powered Research

Premium Access

OPTIZOLINE EYE DROPS 0.05%

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal